Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Masiel Vera"'
Autor:
Carolina Pavlovsky, Bianca Vasconcelos Cordoba, María Belén Sanchez, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, Maria Josefina Freitas, Maria Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Angel Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, Jose Mordoh, Julio Cesar Sanchez Avalos, Gerardo Cueto, Silvia Miranda, Estrella Mariel Levy, Michele Bianchini
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-4 (2023)
Abstract Treatment-free remission (TFR) in chronic myeloid leukemia (CML) is safe under adequate molecular monitoring, but questions remain regarding which factors may be considered predictive for TFR. Argentina Stop Trial (AST) is a multicenter TFR
Externí odkaz:
https://doaj.org/article/8fe9929083cf47d5a46398245f9bd84d
Autor:
María Belén Sanchez, Bianca Vasconcelos Cordoba, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, María Josefina Freitas, María Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Arturo Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, José Mordoh, Julio Cesar Sanchez Avalos, Estrella Mariel Levy, Michele Bianchini
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTreatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the ma
Externí odkaz:
https://doaj.org/article/c31cf40a2c9d4dd98ac2f1617ee73530
Autor:
María Sol Ruiz, Marina Gutiérrez, Michele Bianchini, Javier Gonzalez, Jose Mordoh, Olga Zea, María Eugenia Altuna, Mariana Asinari, Isabel Giere, Carlos Santamaría, Irene Larripa, Analía Seravalle, Evangelina Agrielo, Maria Belen Sanchez, Yuly Masiel Vera Contreras, Maria Noel Zubillaga, Gonzalo Manrique, María Eugenia Monaco, Cecilia Maldonado, María Sol Anchordoqui, Juan Carlos Rozo, Ana Cecilia Granda Alacote, M. E. Alonso, Javier Guerra, Ricardo Makiya, Mauricio Camargo, María Elisa Bonetto
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
The quantitation of BCR-ABL1 mRNA is mandatory for chronic myeloid leukemia (CML) patients, and RT-qPCR is the most extensively used method in testing laboratories worldwide. Nevertheless, substantial variation in RT-qPCR results makes inter-laborato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4885bc502ec284dcfce1fcbf44bc7b3e
https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2019-1283/article-10.1515-cclm-2019-1283.xml
https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2019-1283/article-10.1515-cclm-2019-1283.xml
Autor:
Beatriz Moiraghi, Romina Mariano, María Jose Mela Osorio, Julio Cesar Sanchez Avalos, Maria Cecilia Foncuberta, Josefina Freitas, Miguel A. Pavlovsky, Maria Del Rosario Custidiano, Estrella Mariel Levy, Michele Bianchini, Bianca Vasconcelos Cordoba, Mariana Juni, Carolina Pavlovsky, Veronica Ventriglia, Ana Ines Varela, Maximiliano Luis Riddick, Isolda Fernandez, Ana Garcia de Labanca, Maria Belen Sanchez, Jose Mordoh, Masiel Vera, Isabel Giere, Georgina Bendek
Publikováno v:
Blood. 136:24-24
INTRODUCTION: Long-term survival of patients with chronic myeloid leukemia (CML) has significantly improved since the introduction of BCR-ABL1 tyrosine kinase inhibitors (TKIs). Several considerations about the side effects, risks and cost associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5baac673acd6164c8a4b9417597be57
https://doi.org/10.1182/blood-2020-141067
https://doi.org/10.1182/blood-2020-141067